Brain tumor drug safety under scrutiny: temozolomide liver risk study launched
Disease control
Recruiting now
This study looks at how safe and effective temozolomide (brand name Amitzo) is for people with aggressive brain tumors (grade III and IV gliomas). Researchers are tracking 100 patients to see how often liver injury occurs and to monitor other side effects. The goal is to better u…
Sponsor: NanoAlvand • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC